| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536914 | Vaccine | 2017 | 9 Pages |
Abstract
Both PHiD-CV/dPly/PhtD formulations co-administered with DTPa-HBV-IPV/Hib in infants were well-tolerated and immunogenic for dPly and PhtD antigens, while immune responses to serotype-specific, protein D and co-administered antigens did not appear altered in comparison to PHiD-CV group.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Roman Prymula, Leszek Szenborn, Sven-Arne Silfverdal, Jacek Wysocki, Piotr Albrecht, Magali Traskine, Asparuh Gardev, Yue Song, Dorota Borys,